Showing results (301-310 of 370) with videos related to

Sort By:
Pageof 37
AIDS (London, England)|July 1, 1991
Immunological and virological markers in individuals progressing from seroconversion to AIDSR A Gruters, F G Terpstra, R E De Goede, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 21, 2005
SHARON process evaluated for improved wastewater treatment plant nitrogen effluent qualityR van Kempen, C C R ten Have, S C F Meijer, et al.
AIDS (London, England)|January 12, 2000
Quantitative pp65-antigenemia assay for the prediction of human cytomegalovirus disease in HIV-infected patientsB S Blank, P L Meenhorst, G J Weverling, et al.
Genes, Chromosomes & Cancer|March 1, 1992
Nonradioactive in situ hybridisation of the translocation t(1;7) in myeloid malignanciesR E Kibbelaar, J W Mulder, H van Kamp, et al.
Clinical Drug Investigation|May 31, 2007
Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected IndividualsMonique M R de Maat, Alwin D R Huitema, Jan W Mulder, et al.
British Journal of Clinical Pharmacology|August 27, 2005
Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patientsBregt S Kappelhoff, Alwin D R Huitema, Sanjay U C Sankatsing, et al.
Nature Cell Biology|May 16, 2017
Wounding induces dedifferentiation of epidermal Gata6+ cells and acquisition of stem cell propertiesGiacomo Donati, Emanuel Rognoni, Toru Hiratsuka, et al.
Therapeutic Drug Monitoring|July 17, 2004
Race is not associated with nevirapine pharmacokineticsMonique M R de Maat, Jeannine F J B Nellen, Alwin D R Huitema, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individualsA I Veldkamp, R P van Heeswijk, J W Mulder, et al.
Pageof 37